Skip to content

Effects of Zataria multiflora against oral mucositis induced by radiotherapy

The study of selective radioprotective effects of Zataria multiflora against oral mucositis induced by radiotherapy in cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201305285830N3
Enrollment
20
Registered
2013-08-02
Start date
2013-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral mucositis. Other and unspecified lesions of oral mucosa

Interventions

Intervention 1: From one hour before radio-therapy, patients are given 1% Zataria multiflora mouthwashes, three times daily after breakfast, lunch and dinner for 6 weeks. Each time patients hold 5
Treatment - Drugs
Placebo
From one hour before radio-therapy, patients are given 1% Zataria multiflora mouthwashes, three times daily after breakfast, lunch and dinner for 6 weeks. Each time patients hold 5 ml of mouthwas
From one hour before radio-therapy, patients are given placebo (mouthwashes without Zataria multiflora) , three times daily after breakfast, lunch and dinner for 6 weeks. Each time patients hold

Sponsors

Reasearch & Technology Deputy of Mazandaran medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria are: allergy to Zataria multiflora, preexisting oral conditions, pregnancy , use of other medications related to oral mucositis during study period, any systemic diseases interfering with healing. Inclusion criteria: age older than 18 and less than 60 years; newly diagnosed of head and neck cancers; radio-therapy treatment plan with at least 50 Gray exposure doses to oral filed.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Oral mucositis. Timepoint: Every week for 6 weeks. Method of measurement: Oral Mucositis Assessment Scale- OMAS.

Secondary

MeasureTime frame
Pain. Timepoint: Every week for 6 weeks. Method of measurement: Visual analogue pain scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzar Aghamohammadi

Mazandaran University of Medical Sciences

azareaghamohamady@yahoo.com+98 15 1221 3014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026